The result was further confirmed by an analysis of Aβ levels with an ELISA kit as presented in Figure 2B. Furthermore, we wanted to evaluate whether MemophenolTM was also able to act on two other specific markers of AD disease such as APP and p-Tau. This evidence concerns the gene MAPT and Alzheimer disease.